Table 1. Demographic, anthropometric, biochemical, and clinical data of nonalcoholic fatty liver disease (NAFLD) and control groupsa.
| Characteristics | Controls (n = 159) | NAFLD (n = 156) | P-value | |
|---|---|---|---|---|
| Age (years) | 28.8 (7.3) | 38.5 (8.7) | <0.001 | |
| Body mass index (kg/m2) | 22.9 (3.1) | 29.7 (5.5) | <0.001 | |
| Sex | ||||
| Male | 82 (51.6) | 115 (73.7) | ||
| Female | 77 (48.4) | 41 (26.3) | <0.001 | |
| Smoking history | ||||
| No | 144 (90.6) | 115 (73.7) | ||
| Former | 10 (6.3) | 21 (13.5) | ||
| Current | 5 (3.1) | 20 (12.8) | 0.009 | |
| Systolic blood pressure (mmHg) | 113.9 (13.1) | 124.0 (15.4) | <0.001 | |
| Diastolic blood pressure (mmHg) | 69.9 (8.7) | 75.6 (9.8) | <0.001 | |
| Aspartate aminotransferase (IU/L) | 19.2 (7.1) | 39.9 (17.4) | <0.001 | |
| Alanine aminotransferase (IU/L) | 19.1 (10.5) | 71.8 (40.5) | <0.001 | |
| Gamma glutamyl transferase (IU/L) | 18.2 (8.7) | 59.0 (32.1) | <0.001 | |
| Steatosis | ||||
| Grade 0 | - | |||
| Grade 1 | 41 (26.3) | |||
| Grade 2 | 84 (53.8) | |||
| Grade 3 | 31 (19.9) | |||
| Necroinflammation | ||||
| Grade 0 | 49 (31.4) | |||
| Grade 1 | 58 (37.2) | |||
| Grade 2 | 47 (30.1) | |||
| Grade 3 | 2 (1.3) | |||
| Fibrosis | ||||
| Stage 0 | 89 (57.1) | |||
| Stage 1 | 60 (38.5) | |||
| Stage 2 | 7 (4.4) | |||
| Stage 3 | - | |||
| Stage 4 | - | |||
a
Variables presented as mean (SD) or number (%).